Keywords: Forest Lab, Federal health programs, Howard Solomon, Clinical Data, M&A, HHS-OIG

Forest Labs chief to challenge potential action to exclude him from Federal health care programs; completes Clinical Data buy

Article | 15 April 2011

US drugmaker Forest Laboratories (NYSE: FRX) says that Howard Solomon, its chairman, chief executive and president, will challenge a potential ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in